Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, Carpenter ZW, De Keersmaecker K, Sole X, Xu L, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Meijerink JP, Califano A, Ferrando AA.
Della Gatta G, et al. Among authors: wiernik ph.
Nat Med. 2012 Feb 26;18(3):436-40. doi: 10.1038/nm.2610.
Nat Med. 2012.
PMID: 22366949
Free PMC article.